| 24/06 | ANNEXON, INC.(NASDAQGS: ANNX) dropped from Russell Small Cap Comp Value Index |  |
| 24/06 | ANNEXON, INC.(NASDAQGS: ANNX) dropped from Russell 3000E Index | |
| 24/06 | ANNEXON, INC.(NASDAQGS: ANNX) dropped from Russell 2500 Index | |
| 24/06 | ANNEXON, INC.(NASDAQGS: ANNX) dropped from Russell 2500 Value Index | |
| 24/06 | ANNEXON, INC.(NASDAQGS: ANNX) dropped from Russell 3000E Value Index | |
| 24/06 | ANNEXON, INC.(NASDAQGS: ANNX) dropped from Russell 2000 Dynamic Index | |
| 24/06 | ANNEXON, INC.(NASDAQGS: ANNX) dropped from Russell 2000 Index | |
| 24/06 | ANNEXON, INC.(NASDAQGS: ANNX) dropped from Russell 2000 Value Index | |
| 24/06 | ANNEXON, INC.(NASDAQGS: ANNX) dropped from Russell 3000 Value Index | |
| 24/06 | ANNEXON, INC.(NASDAQGS: ANNX) dropped from Russell 3000 Index | |
| 24/06 | ANNEXON, INC.(NASDAQGS: ANNX) dropped from Russell Small Cap Completeness Index | |
| 10/06 | ANNEXON, INC.: Submission of Matters to a Vote of Security Holders (form 8-K) | |
| 09/06 | TRANSCRIPT: Annexon, Inc. - Shareholder/Analyst Call | |
| 09/06 | TRANSCRIPT: Annexon, Inc. Presents at 2022 Jefferies Global Healthcare Conference, Jun-09.. | |
| 07/06 | ANNEXON: Biosciences Reports Phase 2 Clinical Trial Results Demonstrating Upstream Classi.. | |
| 07/06 | ANNEXON, INC.: Other Events, Financial Statements and Exhibits (form 8-K) | |
| 07/06 | TRANSCRIPT: Annexon, Inc. - Special Call | |
| 07/06 | Annexon Says Huntington's Disease Drug Stabilized Disease Progression in Phase 2 Trial;.. | |
| 07/06 | Annexon Biosciences Reports Phase 2 Clinical Trial Results Demonstrating Upstream Class.. | |
| 07/06 | Annexon Biosciences Reports Phase 2 Clinical Trial Results Demonstrating Upstream Class.. | |
| 07/06 | Annexon, Inc. Reports Phase 2 Clinical Trial Results Demonstrating Upstream Classical C.. | |
| 02/06 | Annexon Biosciences to Present at the 2022 Jefferies Healthcare Conference | |
| 02/06 | Annexon Biosciences to Present at the 2022 Jefferies Healthcare Conference | |
| 01/06 | Annexon Biosciences to Present Data Highlighting Novel Approach to Treating Complement-.. | |
| 01/06 | Annexon Biosciences to Present Data Highlighting Novel Approach to Treating Complement-.. | |
| 12/05 | TRANSCRIPT: Annexon, Inc. Presents at Bank of America 2022 Healthcare Conference, May-12-.. | |
| 09/05 | ANNEXON, INC. Management's Discussion and Analysis of Financial Condition and Results
.. | |
| 09/05 | Annexon Biosciences Highlights Portfolio Progress and Key Anticipated Milestones, and R.. | |
| 09/05 | Annexon, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 | |
| 05/05 | Annexon Biosciences to Participate in Upcoming May Investor Conferences | |
| 05/05 | Annexon Biosciences to Participate in Upcoming May Investor Conferences | |
| 11/04 | TRANSCRIPT: Annexon, Inc. Presents at Needham 21st Annual Healthcare Conference, Apr-11-2.. | |
| 07/04 | ANNEXON: Biosciences Completes Enrollment in ARCHER Phase 2 Trial of Novel C1q Inhibitor,.. | |
| 07/04 | ANNEXON, INC.: Other Events, Financial Statements and Exhibits (form 8-K) | |
| 07/04 | Annexon Concludes Enrollment in Phase 2 Trial of Geographic Atrophy Drug ANX007 | |
| 07/04 | Annexon Biosciences Completes Enrollment in ARCHER Phase 2 Trial of Novel C1q Inhibitor.. | |
| 07/04 | Annexon Biosciences Completes Enrollment in ARCHER Phase 2 Trial of Novel C1q Inhibitor.. | |
| 04/04 | Annexon Biosciences to Participate in the 21st Annual Needham Virtual Healthcare Confer.. | |
| 21/03 | ANNEXON, INC.(NASDAQGS: ANNX) dropped from S&P Biotechnology Select Industry Index | |
| 03/03 | Annexon Biosciences to Present Preclinical Data Supporting Complement Inhibitor Program.. | |
| 01/03 | ANNEXON, INC. Management's Discussion and Analysis of Financial Condition and Results
.. | |
| 01/03 | ANNEXON: Biosciences Announces Program Highlights and Reports Fourth Quarter and Full Yea.. | |
| 01/03 | ANNEXON, INC.: Results of Operations and Financial Condition (form 8-K) | |
| 01/03 | Annexon, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021 | |
| 01/03 | Annexon, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 | |
| 01/03 | Annexon Biosciences Announces Program Highlights and Reports Fourth Quarter and Full Ye.. | |
| 28/02 | Annexon Biosciences to Participate in the Cowen 42nd Annual Healthcare Conference | |
| 22/02 | ANNEXON, INC.: Other Events (form 8-K) | |
| 22/02 | Annexon, Inc. Announces Resignation of Sanjay Keswani as Executive Vice President and C.. | |
| 03/02 | ANNEXON, INC.: Change in Directors or Principal Officers (form 8-K) | |
| 03/02 | Annexon, Inc. Announces Resignation of Ricky Sun as Board Member | |
| 20/01 | ANNEXON: Biosciences Appoints Bettina M. Cockroft, M.D. to its Board of Directors - Form .. | |
| 20/01 | ANNEXON, INC.: Change in Directors or Principal Officers, Regulation FD Disclosure, Finan.. | |
| 20/01 | Annexon Biosciences Appoints Bettina M. Cockroft, M.D. to its Board of Directors | |
| 20/01 | Annexon Biosciences Appoints Bettina M. Cockroft, M.D. to Its Board of Directors | |
| 10/01 | ANNEXON, INC.: Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | |
| 05/01 | Top Midday Decliners | |
| 05/01 | Wall Street Set for Narrow Losses Ahead of Fed Minutes | |
| 05/01 | Health Care Stocks Mixed Ahead of Wednesday's Open | |
| 05/01 | Top Premarket Decliners | |
| 05/01 | Annexon Phase 2 Trial of Treatment Targeting Huntington's Disease 'Well Tolerated' But .. | |
| 04/01 | TRANSCRIPT: Annexon, Inc. - Special Call | |
| 04/01 | ANNEXON, INC.: Other Events, Financial Statements and Exhibits (form 8-K) | |
| 04/01 | Annexon Biosciences Reports Promising Interim Phase 2 Data Showing Improvement in Clini.. | |
| 04/01 | Annexon, Inc. Reports Promising Interim Phase 2 Data Showing Improvement in Clinical Me.. | |
| 04/01 | Annexon Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference | |
| 2021 | ANNEXON, INC.(NASDAQGS: ANNX) added to S&P Biotechnology Select Industry Index | |
| 2021 | Annexon Biosciences Announces Clinical and Preclinical Data Highlighting Potential of C.. | |
| 2021 | Annexon Biosciences Announces Clinical and Preclinical Data Highlighting Potential of C.. | |
| 2021 | Annexon Shares Jump After HC Wainwright Initiates Coverage With Buy Recommendation | |
| 2021 | Annexon Shares Rise After HC Wainwright Begins Coverage at Buy | |
| 2021 | Graphite Bio, Inc. and Annexon, Inc. Enters into A Sublease Agreement for Office and La.. | |
| 2021 | Annexon Biosciences Announces Business and Program Highlights and Reports Third Quarter.. | |
| 2021 | ANNEXON, INC. Management's Discussion and Analysis of Financial Condition and Results
.. | |
| 2021 | Annexon, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept.. | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Espańol
Franēais (France)
Nederlands (Nederland)
Nederlands (Belgiė)
Rapporto
